Orchestra BioMed™ Appoints C. Evan Ballantyne as Chief Financial Officer
December 04, 2018 12:00 ET
|
Orchestra BioMed, Inc.
- Industry veteran brings over 25 years of financial and operational management experience with a proven track record of developing and implementing successful strategies to drive growth and build...
Orchestra BioMed™ to Present at the Piper Jaffray Healthcare Conference
November 20, 2018 13:00 ET
|
Orchestra BioMed, Inc.
NEW HOPE, Pa., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address...
Orchestra BioMed™ Announces Completion of $41 Million Financing
November 15, 2018 10:00 ET
|
Orchestra BioMed, Inc.
Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and hypertension Financing structure provides for up to an additional...
Orchestra BioMed™ Announces AHA 2018 Presentation on BackBeat® Cardiac Neuromodulation Therapy (CNT)
November 08, 2018 13:00 ET
|
Orchestra BioMed, Inc.
- Novel Treatment Delivers Immediate, Substantial, and Sustained Reduction in Blood Pressure - - Potential to Become a Broadly Applicable Therapy for Device-Based Hypertension Management - NEW...
Orchestra BioMed™ Strengthens Operations, R&D and Pharmaceutical Development Expertise with Key Leadership Team Additions
October 10, 2018 09:00 ET
|
Orchestra BioMed, Inc.
– Ron Dadino appointed Vice President, Pharmaceutical Development & Operations, Cardiovascular Interventions – – Greg Kopia, Ph.D., CMPP appointed Director, Pre-Clinical Development,...
Orchestra BioMed™ Adds Three Industry Leaders to Strategic Advisory Board
October 09, 2018 12:00 ET
|
Orchestra BioMed, Inc.
Eric A. Rose, M.D., biotech and medical device business leader as well as world-renowned cardiac surgeon and scientist who performed the landmark achievement of the first successful pediatric heart...
Orchestra BioMed™ Bolsters Leadership Team with Appointment of Inessa Wheeler as Vice President, Strategy and Marketing
October 08, 2018 09:00 ET
|
Orchestra BioMed, Inc.
- Ms. Wheeler brings extensive track record in marketing, strategy and commercial program development - NEW HOPE, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed”...
Orchestra BioMed™ Announces Presentation of Positive 2-Year Clinical Results and Program Update for BackBeat® Cardiac Neuromodulation Therapy at TCT 2018
September 25, 2018 10:15 ET
|
Orchestra BioMed, Inc.
Immediate, Substantial, and Sustained Reduction in Blood Pressure Demonstrates Potential to Offer Highly Differentiated, Breakthrough Treatment for Hypertension SAN DIEGO, Sept. 25, 2018 (GLOBE...
Orchestra BioMed™ Announces Presentation of 3-Year Clinical Results for Virtue® Sirolimus-Eluting Balloon at TCT 2018
September 24, 2018 14:15 ET
|
Orchestra BioMed, Inc.
Excellent Long-Term Safety and Efficacy Profile Demonstrate Potential to Offer Valuable New Treatment for Coronary In-Stent Restenosis SAN DIEGO, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) --...